Information:
Fel:
ID
28946
Beskrivning
Study part: Antibody Sample Collection Screenig. A Phase III, Multicenter, Randomized, Double-Masked, Sham Injection-Controlled Study Of The Efficacy And Safety Of rhuFab V2 (Ranibizumab) In Subjects With Minimally Classic Or Occult Subfoveal Neovascular Age-Related Macular Degeneration.
Nyckelord
Versioner (1)
- 2018-02-18 2018-02-18 -
Rättsinnehavare
Roche
Uppladdad den
18 februari 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Antibody Sample Collection Screenig rhuFab V2 Neovascular Age-Related Macular Degeneration FVF2598g
Antibody Sample Collection Screenig
- StudyEvent: ODM
Similar models
Antibody Sample Collection Screenig
- StudyEvent: ODM
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
ANTIBODY SAMPLE COLLECTION (SCREENING)
C0200345 (UMLS CUI-1)
C0003241 (UMLS CUI-2)
C0003241 (UMLS CUI-2)
Subject Number
Item
Subject Number:
text
C2348585 (UMLS CUI [1])
Subject Initials
Item
Subject Initials:
text
C1997894 (UMLS CUI [1,1])
C2986440 (UMLS CUI [1,2])
C2986440 (UMLS CUI [1,2])
Visit Date
Item
Visit Date:
date
C1320303 (UMLS CUI [1])
Not Done
Item
Not Done
boolean
C1272696 (UMLS CUI [1])
Specimen collection date
Item
Draw Date
date
C1302413 (UMLS CUI [1])
Specimen collection time
Item
Draw Time
time
C4064021 (UMLS CUI [1])
Comment
Item
Comment
text
C0947611 (UMLS CUI [1])